Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Fidson albendazole tablets versus Zentel under fed conditions
PACTR202411565966953Not yet recruiting
- Sponsor
- Fidson Healthcare Plc
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of albendazole in parasitosis (2 arms), sponsored by Fidson Healthcare Plc. Primary endpoints: Cmax of albendazole and AUC0-T of albendazole. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
albendazole
03
Conditions
parasitosis
Beyond the preview
Go deeper on PACTR202411565966953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202411565966953.